Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BBNX NASDAQ:EMBC NASDAQ:IRMD NASDAQ:NNOX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBBNXBeta Bionics$21.25+5.0%$20.53$8.89▼$26.66$923.74MN/A588,443 shs306,060 shsEMBCEmbecta$14.24+1.0%$14.25$9.20▼$21.48$834.29M1.1572,774 shs23,268 shsIRMDiRadimed$74.45-0.3%$71.92$46.86▼$78.38$950.21M1.0245,724 shs4,524 shsNNOXNano-X Imaging$4.14-2.0%$3.99$3.60▼$11.00$238.34M1.891.66 million shs257,695 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBBNXBeta Bionics+1.10%-8.62%-9.88%+35.29%+2,023,999,900.00%EMBCEmbecta+3.98%+5.62%-1.67%+31.90%+3.37%IRMDiRadimed+1.72%+3.15%+5.91%+32.66%+44.16%NNOXNano-X Imaging+5.76%+3.94%+6.30%-22.85%-31.05%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBBNXBeta Bionics$21.25+5.0%$20.53$8.89▼$26.66$923.74MN/A588,443 shs306,060 shsEMBCEmbecta$14.24+1.0%$14.25$9.20▼$21.48$834.29M1.1572,774 shs23,268 shsIRMDiRadimed$74.45-0.3%$71.92$46.86▼$78.38$950.21M1.0245,724 shs4,524 shsNNOXNano-X Imaging$4.14-2.0%$3.99$3.60▼$11.00$238.34M1.891.66 million shs257,695 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBBNXBeta Bionics+1.10%-8.62%-9.88%+35.29%+2,023,999,900.00%EMBCEmbecta+3.98%+5.62%-1.67%+31.90%+3.37%IRMDiRadimed+1.72%+3.15%+5.91%+32.66%+44.16%NNOXNano-X Imaging+5.76%+3.94%+6.30%-22.85%-31.05%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBBNXBeta Bionics 2.69Moderate Buy$24.5615.56% UpsideEMBCEmbecta 2.20Hold$19.0033.43% UpsideIRMDiRadimed 3.00Buy$72.00-3.29% DownsideNNOXNano-X Imaging 3.00Buy$8.50105.56% UpsideCurrent Analyst Ratings BreakdownLatest NNOX, IRMD, BBNX, and EMBC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/21/2025BBNXBeta BionicsStifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$26.0010/8/2025BBNXBeta BionicsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)10/8/2025EMBCEmbectaWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C-)10/8/2025IRMDiRadimedWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy (B-)10/8/2025NNOXNano-X ImagingWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/7/2025EMBCEmbectaZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold10/1/2025BBNXBeta BionicsThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetNeutral ➝ Buy$18.00 ➝ $26.0010/1/2025BBNXBeta BionicsThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy$18.00 ➝ $26.009/27/2025BBNXBeta BionicsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)9/27/2025EMBCEmbectaWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C-)9/27/2025IRMDiRadimedWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy (B-)(Data available from 10/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBBNXBeta Bionics$65.12M14.19N/AN/A($5.72) per share-3.72EMBCEmbecta$1.10B0.76$3.51 per share4.06($12.80) per share-1.11IRMDiRadimed$73.24M12.93$1.60 per share46.41$6.85 per share10.87NNOXNano-X Imaging$11.28M21.18N/AN/A$3.27 per share1.26Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBBNXBeta Bionics-$54.76MN/A0.00∞N/AN/AN/AN/AN/AEMBCEmbecta$78.30M$1.439.984.640.757.58%-23.40%14.46%11/25/2025 (Estimated)IRMDiRadimed$19.23M$1.6246.1137.23N/A26.61%23.30%20.62%10/30/2025 (Estimated)NNOXNano-X Imaging-$53.52M-$0.90N/AN/AN/A-468.29%-32.09%-28.73%11/20/2025 (Estimated)Latest NNOX, IRMD, BBNX, and EMBC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/30/2025Q3 2025IRMDiRadimed$0.43N/AN/AN/A$20.50 millionN/A8/12/2025Q2 2025NNOXNano-X Imaging-$0.15-$0.23-$0.08-$0.23$3.20 million$3.04 million8/8/2025Q3 2025EMBCEmbecta$0.7720$1.12+$0.3480$0.78$278.15 million$295.50 million7/29/2025Q2 2025BBNXBeta Bionics-$0.51-$0.39+$0.12-$0.39$19.73 million$23.24 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBBNXBeta BionicsN/AN/AN/AN/AN/AEMBCEmbecta$0.604.21%N/A41.96%N/AIRMDiRadimed$0.680.91%N/A41.98%1 YearsNNOXNano-X ImagingN/AN/AN/AN/AN/ALatest NNOX, IRMD, BBNX, and EMBC DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/6/2025EMBCEmbectaquarterly$0.154.14%8/29/20258/29/20259/15/20257/31/2025IRMDiRadimedquarterly$0.171.13%8/18/20258/18/20258/28/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBBNXBeta BionicsN/A14.6813.79EMBCEmbectaN/A2.471.78IRMDiRadimedN/A8.787.51NNOXNano-X ImagingN/A4.194.03Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBBNXBeta BionicsN/AEMBCEmbecta93.83%IRMDiRadimed92.34%NNOXNano-X Imaging21.49%Insider OwnershipCompanyInsider OwnershipBBNXBeta BionicsN/AEMBCEmbecta0.42%IRMDiRadimed36.80%NNOXNano-X ImagingN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBBNXBeta Bionics29443.47 millionN/AN/AEMBCEmbecta2,10058.49 million58.24 millionOptionableIRMDiRadimed11012.72 million8.04 millionOptionableNNOXNano-X Imaging19057.78 millionN/AOptionableNNOX, IRMD, BBNX, and EMBC HeadlinesRecent News About These CompaniesGriffin Asset Management Inc. Has $605,000 Position in Nano-X Imaging Ltd. $NNOXOctober 13, 2025 | marketbeat.comNano-X Imaging's (NNOX) Sell (D-) Rating Reiterated at Weiss RatingsOctober 10, 2025 | marketbeat.comNanox Partners with Monarch to Expand Access to Advanced 3D ImagingSeptember 19, 2025 | finance.yahoo.comNanox Announces Multi-Segment Healthcare Collaboration with Monarch Medical Management to Expand Access to Advanced Medical ImagingSeptember 18, 2025 | globenewswire.comNano-X Imaging Earnings Call: Mixed Outlook with Strategic ProgressSeptember 2, 2025 | theglobeandmail.comNano-X Imaging: Still No Opportunity HereAugust 13, 2025 | seekingalpha.comNano-X Imaging Ltd. (NASDAQ:NNOX) Q2 2025 Earnings Call TranscriptAugust 13, 2025 | msn.comNano-X Imaging Reports Q2 2025 Financial ResultsAugust 13, 2025 | msn.comNano-X Imaging Reports Q2 2025 Results and Expands Market ReachAugust 12, 2025 | msn.comNano-X Imaging Ltd. (NNOX) Q2 2025 Earnings Call TranscriptAugust 12, 2025 | seekingalpha.comNano X Imaging Ltd (NNOX) Q2 2025 Earnings Report Preview: What To ExpectAugust 11, 2025 | finance.yahoo.comEarnings Preview For Nano X ImagingAugust 11, 2025 | benzinga.comNanox to Report Second Quarter 2025 Financial Results on August 12, 2025August 1, 2025 | globenewswire.comNanox Announces Clinical and Educational Collaboration with Keiser University Featuring the Nanox.ARCJuly 1, 2025 | globenewswire.comNanox Imaging to Present at the Investor Summit Virtual on June 10, 2025June 9, 2025 | accessnewswire.comANanox Receives MDR CE Mark for HealthOST, an Advanced AI-Powered Software for Spine AssessmentJune 5, 2025 | globenewswire.comNanox to Participate in Sidoti Small Cap ConferenceJune 3, 2025 | globenewswire.comWhat Does The Future Hold For Nano-X Imaging Ltd. (NASDAQ:NNOX)? These Analysts Have Been Cutting Their EstimatesMay 27, 2025 | finance.yahoo.comNano-X Imaging Ltd. (NASDAQ:NNOX) Q1 2025 Earnings Call TranscriptMay 24, 2025 | insidermonkey.comNano-X Imaging price target lowered to $7 from $9 at Alliance Global PartnersMay 23, 2025 | finance.yahoo.comNano X Imaging Ltd (NNOX) Q1 2025: Everything You Need To Know Ahead Of EarningsMay 23, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNNOX, IRMD, BBNX, and EMBC Company DescriptionsBeta Bionics NASDAQ:BBNX$21.25 +1.01 (+4.99%) As of 10:27 AM EasternBeta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.Embecta NASDAQ:EMBC$14.24 +0.14 (+0.99%) As of 10:44 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.iRadimed NASDAQ:IRMD$74.45 -0.24 (-0.32%) As of 10:43 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.Nano-X Imaging NASDAQ:NNOX$4.14 -0.09 (-2.01%) As of 10:44 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Will D-Wave's European Expansion Keep Fueling the Rally? Navitas Soars 78% on NVIDIA Update: Is This Rally Sustainable? Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done Yet Waymo’s Global Expansion Strengthens the Case for GOOGL Stock Broadcom Inks OpenAI Deal: Why It's A Huge Win for AVGO Stock Meta vs OpenAI: Is Sora a True Threat to Meta's Dominance? Institutions Are Fueling CrowdStrike’s Next Leg Higher This AI Chip Giant Could Be the Market’s Next Big Winner Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
